Envista/NVST

$21.92

-3.22%
-
1D1W1MYTD1YMAX

About Envista

Envista Holdings Corporation is a dental products company. The Company provides dental consumables, solutions, technology, and services. It has approximately 30 dental brands, including Nobel Biocare, Ormco and Kerr united. The Company operates through two segments: Specialty Products & Technologies and Equipment & Consumables. The Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Equipment & Consumables segment develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems, and endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents and cements, and infection prevention products.

Ticker

NVST

Sector

Healthcare

Trading on

NYSE

Industry

Medical Equipment & Supplies

CEO

Amir Aghdaei

Employees

12,800

Headquarters

Brea, United States

Envista Metrics

BasicAdvanced
$3.89B
Market cap
-
P/E ratio
-$0.60
EPS
1.37
Beta
-
Dividend rate

What the Analysts think about Envista

Analyst Ratings

Majority rating from 13 analysts.
Hold

Price Targets

Average projection from 10 analysts.
9.49% upside
High $33.00
Low $19.00
$21.92
Current price
$24.00
Average price target

Envista Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-33.67% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$645.6M
2.27%
Net income
$-217.4M
-1,111.16%
Profit margin
-33.67%
-1,090.29%

Envista Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 14.82%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
$0.38
$0.43
$0.43
$0.29
-
Expected
$0.41
$0.41
$0.46
$0.34
$0.32
Surprise
-8.01%
4.78%
-6.11%
-14.82%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Envista stock

Buy or sell Envista stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing